DEA
The DEA Relaxed Online Prescribing Rules During Covid. Now It Wants to Rein Them In.
Arielle Zionts June 27, 2023 Federal regulators want most patients to see a health care provider in person before receiving prescriptions for potentially addictive medicines through telehealth — something that hasn’t been required in more than three years. During the covid-19 public health emergency, the Drug Enforcement Administration allowed doctors and other health care providers […]
Read MoreNEW: DEA Temporarily Extends Flexibilities for Telehealth Prescribing
Yesterday, May 9, 2023, the Drug Enforcement Agency (DEA) and the Substance Abuse & Mental Health Services Administration (SAMHSA) issued a temporary rule that extends telemedicine flexibilities regarding prescription of controlled medications. The goal of the rule is to ensure a smooth transition for patients and practitioners that have come to rely on the availability […]
Read MoreUpdate on DEA Proposed Rule on Telemedicine Prescribing
In late February 2023 (see NAHC Report), the Drug Enforcement Agency (DEA) proposed a rule intended to govern the prescribing of controlled substances via telemedicine for application at the end of the COVID-19 Public Health Emergency (PHE). The proposed rule focuses on prescribing of a controlled substance via telemedicine consultation by a medical practitioner when no in-person […]
Read MoreDEA Proposes Rules to Govern Post-PHE Prescribing of Controlled Substances via “Telehealth”
On Friday, February 24, 2023, the Drug Enforcement Administration (DEA) released proposed rules intended to govern the prescribing of controlled substances via telemedicine for application at the end of the COVID-19 Public Health Emergency (PHE). The proposed rule — — Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a […]
Read MoreBiden Admin Relaxes Prescribing Requirements for Popular Opioid Use Disorder Drug
The Department of Health and Human Services (HHS) released updated guidance that removes some of the prescribing barriers for the drug buprenorphine, a medication that is commonly to treat opioid use disorder (OUD). As providers, especially those in hospice and palliative care, continue to serve increasing numbers of patients with OUDs that are managed on […]
Read More
